Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Current Leases (2019 - 2025)

Cue Biopharma (CUE) has disclosed Current Leases for 7 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • Quarterly Current Leases fell 46.02% to $1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, down 46.02% year-over-year, with the annual reading at $1.9 million for FY2025, 46.02% down from the prior year.
  • Current Leases hit $1.9 million in Q4 2025 for Cue Biopharma, down from $2.0 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $5.4 million in Q1 2022 to a low of $700000.0 in Q4 2022.
  • Historically, Current Leases has averaged $3.3 million across 5 years, with a median of $3.4 million in 2023.
  • Biggest five-year swings in Current Leases: tumbled 85.81% in 2022 and later soared 381.14% in 2023.
  • Year by year, Current Leases stood at $4.9 million in 2021, then crashed by 85.81% to $700000.0 in 2022, then skyrocketed by 381.14% to $3.4 million in 2023, then increased by 5.11% to $3.5 million in 2024, then crashed by 46.02% to $1.9 million in 2025.
  • Business Quant data shows Current Leases for CUE at $1.9 million in Q4 2025, $2.0 million in Q3 2025, and $2.1 million in Q2 2025.